162 related articles for article (PubMed ID: 26063416)
21. Analysis of 320 gastroenteropancreatic neuroendocrine tumors identifies TS expression as independent biomarker for survival.
Lee HS; Chen M; Kim JH; Kim WH; Ahn S; Maeng K; Allegra CJ; Kaye FJ; Hochwald SN; Zajac-Kaye M
Int J Cancer; 2014 Jul; 135(1):128-37. PubMed ID: 24347111
[TBL] [Abstract][Full Text] [Related]
22. PROX1 expression in gastric cancer: from hypothesis to evidence.
Taban O; Cimpean AM; Raica M; Olariu S
Anticancer Res; 2014 Jul; 34(7):3439-46. PubMed ID: 24982352
[TBL] [Abstract][Full Text] [Related]
23. Expression of PROX1 Is a common feature of high-grade malignant astrocytic gliomas.
Elsir T; Eriksson A; Orrego A; Lindström MS; Nistér M
J Neuropathol Exp Neurol; 2010 Feb; 69(2):129-38. PubMed ID: 20084020
[TBL] [Abstract][Full Text] [Related]
24. Clinical impact of atypical endoscopic features in rectal neuroendocrine tumors.
Hyun JH; Lee SD; Youk EG; Lee JB; Lee EJ; Chang HJ; Sohn DK
World J Gastroenterol; 2015 Dec; 21(47):13302-8. PubMed ID: 26715813
[TBL] [Abstract][Full Text] [Related]
25. Prognostic Impact of LGR5, Prox1, and Notch1 Biomarkers in Stage II to III Colon Cancer.
Abdelrahman AE; El-Azony A; Elsebai E; Ibrahim HM
Appl Immunohistochem Mol Morphol; 2022 Feb; 30(2):126-135. PubMed ID: 34657081
[TBL] [Abstract][Full Text] [Related]
26. PDX-1, CDX-2, TTF-1, and CK7: a reliable immunohistochemical panel for pancreatic neuroendocrine neoplasms.
Chan ES; Alexander J; Swanson PE; Jain D; Yeh MM
Am J Surg Pathol; 2012 May; 36(5):737-43. PubMed ID: 22498824
[TBL] [Abstract][Full Text] [Related]
27. Targeted next-generation sequencing of well-differentiated rectal, gastric, and appendiceal neuroendocrine tumors to identify potential targets.
Park HY; Kwon MJ; Kang HS; Kim YJ; Kim NY; Kim MJ; Min KW; Choi KC; Nam ES; Cho SJ; Park HR; Min SK; Seo J; Choe JY; Lee HK
Hum Pathol; 2019 May; 87():83-94. PubMed ID: 30851333
[TBL] [Abstract][Full Text] [Related]
28. Expression of Sex Determining Region Y-Box 2 and Pancreatic and Duodenal Homeobox 1 in Pancreatic Neuroendocrine Tumors.
Akiyama T; Shida T; Yoshitomi H; Takano S; Kagawa S; Shimizu H; Ohtsuka M; Kato A; Furukawa K; Miyazaki M
Pancreas; 2016 Apr; 45(4):522-7. PubMed ID: 26491904
[TBL] [Abstract][Full Text] [Related]
29. Well-differentiated rectal neuroendocrine tumors: analysis of histology, including insulinoma-associated protein 1 expression, and biologic behavior, involving a large cohort of 94 cases.
Sappenfield R; Gonzalez IA; Cao D; Chatterjee D
Hum Pathol; 2020 Oct; 104():66-72. PubMed ID: 32763255
[TBL] [Abstract][Full Text] [Related]
30. Clinicopathological characteristics and frequency of multiple rectal neuroendocrine tumors: a single-center retrospective study.
Nishikawa Y; Chino A; Ide D; Saito S; Igarashi M; Takamatsu M; Fujisaki J; Igarashi Y
Int J Colorectal Dis; 2019 Nov; 34(11):1887-1894. PubMed ID: 31630212
[TBL] [Abstract][Full Text] [Related]
31. PROX1 lymphatic density correlates with adverse clinicopathological factors, lymph node metastases and survival in neuroblastomas.
Ramani P; Norton A; Somerville MS; May MT
J Neurooncol; 2012 Jul; 108(3):375-83. PubMed ID: 22382784
[TBL] [Abstract][Full Text] [Related]
32. [Differential diagnostic value of the expression of the transcription factor PDX-1 in neuroendocrine and non-neuroendocrine tumors of the pancreas and other organs].
Gurevich LE; Proshchina AE; Voronkova IA; Ashevskaya VE; Korosteleva PA; Dolzhansky OV
Arkh Patol; 2019; 81(5):11-21. PubMed ID: 31626200
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical Characterization of the Origins of Metastatic Well-differentiated Neuroendocrine Tumors to the Liver.
Yang Z; Klimstra DS; Hruban RH; Tang LH
Am J Surg Pathol; 2017 Jul; 41(7):915-922. PubMed ID: 28498280
[TBL] [Abstract][Full Text] [Related]
34. The clinicopathological significance of angiogenesis in hindgut neuroendocrine tumors obtained via an endoscopic procedure.
Okubo Y; Motohashi O; Nakayama N; Nishimura K; Kasajima R; Miyagi Y; Shiozawa M; Yoshioka E; Suzuki M; Washimi K; Kawachi K; Nito M; Kameda Y; Yokose T
Diagn Pathol; 2016 Nov; 11(1):128. PubMed ID: 27821179
[TBL] [Abstract][Full Text] [Related]
35. Well-Differentiated Neuroendocrine Tumor-A Low b-Grade Tumor's Aggressive Course and Dismal Outcome: A Case Report.
Atwal D; Joshi KP; Jeffus S; Ntambi J; Mahmoud F
Perm J; 2017; 21():16-193. PubMed ID: 28633725
[TBL] [Abstract][Full Text] [Related]
36. Novel Finding of Paired Box 5 (PAX5) Cytoplasmic Staining in Well-differentiated Rectal Neuroendocrine Tumors (Carcinoids) and Its Diagnostic and Potentially Prognostic Utility.
Fu Z; Zuo C; Sheehan CE; Patil DT; Lin J; Yang Z; Lee H
Appl Immunohistochem Mol Morphol; 2019 Jul; 27(6):454-460. PubMed ID: 29561272
[TBL] [Abstract][Full Text] [Related]
37. Length of lymphangiogenesis in the rectal tissues distal to rectal cancer.
Li LR; Fang YJ; Pan ZZ; Wu XJ; Wan DS; Hardingham JE; Rieger N
Tumour Biol; 2010 Dec; 31(6):667-71. PubMed ID: 20680711
[TBL] [Abstract][Full Text] [Related]
38. The expression and prognostic significance of bcl-2-associated transcription factor 1 in rectal cancer following neoadjuvant therapy.
Brown GT; Cash B; Alnabulsi A; Samuel LM; Murray GI
Histopathology; 2016 Mar; 68(4):556-66. PubMed ID: 26183150
[TBL] [Abstract][Full Text] [Related]
39. Recurrence 30 Years after Surgical Resection of a Localized Rectal Neuroendocrine Tumor.
Shigematsu Y; Kanda H; Konishi T; Takazawa Y; Inoue Y; Muto T; Ishikawa Y; Takahashi S
Intern Med; 2017; 56(12):1521-1525. PubMed ID: 28626177
[TBL] [Abstract][Full Text] [Related]
40. Islet 1 (Isl1) expression is a reliable marker for pancreatic endocrine tumors and their metastases.
Schmitt AM; Riniker F; Anlauf M; Schmid S; Soltermann A; Moch H; Heitz PU; Klöppel G; Komminoth P; Perren A
Am J Surg Pathol; 2008 Mar; 32(3):420-5. PubMed ID: 18300808
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
